DNMT1 is primarily responsible for maintaining methylation during DNA replication and is frequently upregulated in AML, where it contributes to persistent silencing of genes such as TP53 and CDKN2A, thereby impairing apoptosis and attenuating DNA damage responses (Ling et al., 2023). The gene discussed is CDKN2A; the disease is acute myeloid leukemia.